Nevertheless, despite blocking IRE1’s enzymatic activity effectively, neither IRE1 inhibitor attenuated proliferation in vitro or tumor growth in vivo of AMO1 cells—similar to the non-targeted shRNA control (shNTC), and in sharp contrast to a robust growth disruption by IRE1 knockdown (Fig 1D and 1E). This evidence concerns the gene ERN1 and neoplasm.